Abstract
Background A 49-year-old man presented to a rheumatology clinic with a 2-month history of low back pain. The pain seemed to be inflammatory in origin, with nocturnal occurrence and substantial early morning stiffness. The patient was previously well, with no history of psoriasis, inflammatory bowel disease or iritis.
Investigations Physical examination, anteroposterior X-ray of the pelvis, isotope bone scan, CT and MRI of the sacroiliac joints, measurement of serum inflammatory markers, HLA-B27 testing, routine and mycobacterial culture of the sacroiliac joint fluid aspirate, tuberculosis skin testing and chest X-ray.
Diagnosis An HLA-B27-negative patient with chronic unilateral sacroiliitis refractory to conventional management.
Management After unsuccessful treatment with various NSAIDs and physical therapy, local corticosteroid injections on two occasions in the affected sacroiliac joint provided transient relief. A subsequent 20 mg injection of infliximab into the affected joint resulted in clinical and radiological improvement that has been sustained for more than 2 years.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
van der Linden S et al. (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27: 361–368
Dougados M et al. (1991) The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 34: 1218–1227
Zochling J et al. (2006) ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 65: 442–452
Braun J et al. (2008) Persistent clinical efficacy and safety of anti-tumour necrosis factor alpha therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response. Ann Rheum Dis 67: 340–345
Conti F et al. (2005) Successful treatment with intra-articular infliximab for resistant knee monoarthritis in a patient with spondylarthropathy: a role for scintigraphy with 99mTc-infliximab. Arthritis Rheum 52: 1224–1226
Schatteman L et al. (2006) Treatment of refractory inflammatory monoarthritis in ankylosing spondylitis by intraarticular injection of infliximab. J Rheumatol 33: 82–85
Sakellariou GT et al. (2006) Intraarticular injection of infliximab. J Rheumatol 33: 1912–1913
Fisher BA and Keat A (2006) Should we be using intraarticular tumor necrosis factor blockade in inflammatory monoarthritis? J Rheumatol 33: 1934–1935
Kellner H et al. (2002) Successful therapy of sacroiliitis in AS patients by intraarticular injection of infliximab. Arthritis Rheum 46: S431
Bokarewa M and Tarkowski A (2003) Local infusion of infliximab for the treatment of acute joint inflammation. Ann Rheum Dis 62: 783–784
Ahern MJ et al. (2008) Effect of intra-articular infliximab on synovial membrane pathology in a patient with a seronegative spondyloarthropathy. Ann Rheum Dis 67: 1339–1342
Alstergren P et al. (2008) Successful treatment with multiple intra-articular injections of infliximab in a patient with psoriatic arthritis. Scand J Rheumatol 37: 155–157
Nikas SN et al. (2004) Treatment of resistant rheumatoid arthritis by intra-articular infliximab injections: a pilot study. Ann Rheum Dis 63: 102–103
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
D Salonen and R Inman declared that have both acted as consultants for Schering/Centocor, Amgen/Wyeth and Abbott. The other authors declared no competing interests.
Rights and permissions
About this article
Cite this article
O'Shea, F., Haroon, N., Salonen, D. et al. Clinical and radiographic response to a local infliximab injection in a patient with chronic sacroiliitis. Nat Rev Rheumatol 5, 171–173 (2009). https://doi.org/10.1038/ncprheum1003
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncprheum1003